Navigation Links
Sagent Pharmaceuticals and Actavis Enter Into Exclusive U.S. Development, Supply and Marketing Collaboration for a Portfolio of Specialty Injectable Pharmaceutical Products
Date:5/4/2010

SCHAUMBURG, Ill. and MORRISTOWN, N.J., May 4 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, and Actavis Inc., a leading global generic pharmaceutical manufacturer, have launched an exclusive collaboration to develop and market a select group of specialty injectable medications for the United States.

Under the agreement, Actavis will develop, obtain U.S. Food and Drug Administration approval, and supply the products, which Sagent will market in the United States. Financial terms of the agreement have not been disclosed.

"Actavis' impressive injectable pipeline, substantial development and supply capabilities and excellent record of execution make Actavis an outstanding partner for Sagent," said Jeffrey M. Yordon, Sagent's chief executive officer, founder and chairman of the board. "This collaboration complements Sagent's strategy by quickly adding products to our marketed portfolio and we look forward to working with Actavis to expand our collective portfolio."

Doug Boothe, chief executive officer of Actavis Inc., said the strategic collaboration with Sagent will enable consumers in the United States to benefit from the company's global expertise in developing and manufacturing specialty injectable products.

"By combining our injectable pipeline with Sagent's and partnering with their sales and marketing team, we have increased our potential to serve the U.S. market for these valuable products beyond what either of our companies could have achieved independently," Boothe said. Headquartered in Morristown, N.J., Actavis Inc. is the U.S. subsidiary of Iceland-based Actavis Group.  

About Sagent Pharmaceuticals

Sagent Pharmaceuticals is a privately held specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products.  Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients.

To Discover Injectables Excellence™ and learn more about Sagent, please visit www.SagentPharma.com.

About Actavis Inc.

Actavis Inc. is the U.S. subsidiary of Actavis Group hf. Approximately one quarter of Actavis' sales are generated in North America, Actavis' single largest market. Based in Morristown, NJ, Actavis has U.S. manufacturing facilities in Elizabeth, NJ; Little Falls, NJ; Totowa, NJ; and Lincolnton, NC. Actavis also has research and development facilities in Owings Mills, MD and Sunrise, FL; and a packaging facility in Totowa, NJ. Please visit www.actavis.us for more information.


'/>"/>
SOURCE Sagent Pharmaceuticals, Inc.; Actavis Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sagent Pharmaceuticals Announces U.S. FDA Tentative Approval of Additional Adenosine Injection, USP Vial Presentations
2. Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP
3. Sagent Pharmaceuticals Launches Pamidronate Disodium Injection
4. Sagent Pharmaceuticals Bolsters Antibiotics Offering With Two Product Launches
5. Sagent Pharmaceuticals to Present at Piper Jaffray Health Care Conference
6. Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences
7. Sagent Pharmaceuticals Launches Vinorelbine Injection, USP
8. Sagent Pharmaceuticals Announces Launch of Adenosine Injection, USP, in 6 mg per 2 mL Single-Dose Vials
9. Epix Pharmaceuticals, Inc. Announces the May 28, 2010 Auction Sale of EP-3600 MRI Imaging Agent
10. Reportlinker Adds The Outlook for Pharmaceuticals in Western Europe
11. ISTA Pharmaceuticals to Present at the Ninth Annual JMP Securities Research Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/11/2019)... ... 11, 2019 , ... PRP Science , Florida’s leading medical distribution company ... of the most respected manufacturers in the medical aesthetics arena; Ameia Med ... the leading developer of the EXCEED micro-needling device (MN). Recognized as ...
(Date:11/11/2019)... ... November 11, 2019 , ... A highly experienced orthopedic ... Jarman adds a new dimension to Advanced Bone and Joint, by offering his ... experience, Dr. Jarman is trained in the evaluation and treatment of injuries and ...
(Date:11/11/2019)... ... November 10, 2019 , ... A gifted actor and generous philanthropist, Laurence Fishburne, ... on an episode of "Behind The Scenes." The growth of health management tools in ... medical staff. This segment will focus on which tools are the most successful in ...
Breaking Medicine Technology:
(Date:11/14/2019)... ... November 14, 2019 , ... EMulate Therapeutics, Inc., ... diseases, announced it will have 5 poster presentations related to its medical devices ... for Neuro-Oncology SNO Meeting in Phoenix, beginning on November 20 . ...
(Date:11/14/2019)... ... November 14, 2019 , ... With winter just around the corner, parents want to ... padded jackets and overalls might keep little ones warm, during a car ride they can ... car seat must fit snugly in order to ensure maximum safety during a crash or ...
(Date:11/12/2019)... MILL, S.C. (PRWEB) , ... November 12, 2019 ... ... physician practices and health systems, today announced that Tidewater Physicians Multispecialty Group ... Virginia, has selected the Healthy Outcomes® patient engagement platform to deliver ...
(Date:11/11/2019)... , ... November 11, 2019 , ... Early praise for ... breaks down the complexities of scholarly writing and provides key insight and vital guidance ... or DNP Project will have a permanent place on my bookshelf and will be ...
(Date:11/11/2019)... ... November 11, 2019 , ... Last year’s expo was a resounding success ... box buyers like Costco, Walmart, and GNC. Exhibitors included some of the biggest ... , This year, CBD.io and partners, are once again set to ...
Breaking Medicine News(10 mins):